{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:08:30Z","timestamp":1773284910379,"version":"3.50.1"},"reference-count":27,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T00:00:00Z","timestamp":1563840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:sec><jats:title>Aims<\/jats:title><jats:p>The primary aims of the study were to identify those medications most frequently associated with clinical litigation in Ireland and to quantify the cost of such litigation. Secondary aims were to identify where in the medication\u2010use process claims were most likely to arise, the medication incident types involved and the primary injury alleged.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The National Incident Management System (NIMS) for incident and claims management was searched to identify all medication\u2010related claims finalised from 2011 to 2016 (inclusive). The physical case files were obtained and additional data not available on NIMS was extracted in order to build a detailed picture of the incident and subsequent claim.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The search identified 79 relevant claims, of which 48 closed with a payment to the plaintiff. These 48 claims involved 54 medications. Medication groups identified included general anaesthetics (<jats:italic>n<\/jats:italic>\u00a0=\u00a07), opioids (<jats:italic>n<\/jats:italic>\u00a0=\u00a06), penicillins, antithrombotics and local anaesthetics (all <jats:italic>n<\/jats:italic>\u00a0=\u00a05). The errors alleged occurred exclusively at the administration (58%) and prescribing (42%) stages of the medication\u2010use process. Medication incident types included wrong dose\/strength (<jats:italic>n<\/jats:italic>\u00a0=\u00a017), wrong drug (<jats:italic>n<\/jats:italic>\u00a0=\u00a07) and adverse drug reaction (<jats:italic>n<\/jats:italic>\u00a0=\u00a06). The most commonly pleaded primary injuries were allergic reaction (<jats:italic>n<\/jats:italic>\u00a0=\u00a09), deterioration in clinical status (n\u00a0=\u00a09) and post\u2010traumatic stress disorder (<jats:italic>n<\/jats:italic>\u00a0=\u00a08). The median total cost of these claims was \u20ac60\u00a0991, including median damages of \u20ac33\u00a0858.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This study links data on medication incidents, actual harm to patients and litigation costs. Thus, it presents a comprehensive picture of the consequences of medication error.<\/jats:p><\/jats:sec>","DOI":"10.1111\/bcp.14035","type":"journal-article","created":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T11:14:11Z","timestamp":1561029251000},"page":"2155-2162","source":"Crossref","is-referenced-by-count":4,"title":["Medication related litigation in Ireland: A 6\u2010year review"],"prefix":"10.1111","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5316-3941","authenticated-orcid":false,"given":"Mark","family":"McCullagh","sequence":"first","affiliation":[{"name":"Clinical Risk Unit State Claims Agency  Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dubhfeasa","family":"Slattery","sequence":"additional","affiliation":[{"name":"Medical Professionalism Royal College of Surgeons in Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2019,7,23]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.2147\/OAEM.S64174"},{"key":"e_1_2_11_3_1","unstructured":"Institute for Safe Medication Practices Canada.Definitions of Terms[Internet]. ISMP Canada;2017[cited 2018 January 25]. Available from:https:\/\/www.ismp\u2010canada.org\/definitions.htm."},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-016-0358-1"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2011.04166.x"},{"key":"e_1_2_11_6_1","unstructured":"ElliottRA CamachoE CampbellR JankovicD Martyn St JamesM KaltenthalerEet al.Prevalence and Economic Burden of Medication Errors in the NHS in England. Policy Research Unit in Economic Evaluation of Health & Care Interventions (EEPRU)[Internet]. EEPRU;2018[cited 2019 April 3]. Available from:http:\/\/www.eepru.org.uk\/wp\u2010content\/uploads\/2018\/02\/eepru\u2010report\u2010medication\u2010error\u2010feb\u20102018.pdf."},{"key":"e_1_2_11_7_1","unstructured":"SlatteryD WalshD O'Byrne MaguireI O'ReganC KennedyM McCrohanK McCullaghM.National Clinical Incidents Claims and Costs Report. Lessons learned a five year review: 2010\u20132014[Internet]. Dublin: State Claims Agency;2017[cited 2018 January 25]. Available from:http:\/\/stateclaims.ie\/wp\u2010content\/uploads\/2017\/05\/State\u2010Claims\u2010Agency\u2010National\u2010Clinical\u2010Incidents\u2010Claims\u2010and\u2010Costs\u2010Report.pdf."},{"key":"e_1_2_11_8_1","unstructured":"WHO Collaborating Centre for Patient Safety Solutions.Assuring Medication Accuracy at Transitions in Care[Internet]. WHO Patient Safety Solutions volume 1 solution 6;2007[cited 2018 February 23]. Available from:http:\/\/www.who.int\/patientsafety\/solutions\/patientsafety\/PS\u2010Solution6.pdf."},{"key":"e_1_2_11_9_1","unstructured":"WHO Service Delivery and Safety.Medication Without Harm: WHO Global Patient Safety Challenge[Internet]. Geneva: WHO;2017[cited 2018 May 30]. Available from:http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/255263\/WHO\u2010HIS\u2010SDS\u20102017.6\u2010eng.pdf;jsessionid=083EC1DBB4A93AF31377CBDF14E83E84?sequence=1."},{"issue":"7","key":"e_1_2_11_10_1","first-page":"1","article-title":"National burden of preventable adverse drug events associated with inpatient injectable medications: healthcare and medical professional liability costs","volume":"5","author":"Lahue BJ","year":"2012","journal-title":"Am Health Drug Benefits"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4188"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.2009.06107.x"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2010.03834.x"},{"key":"e_1_2_11_14_1","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology.ATC: Structure and principles[Internet]. Oslo: WHO;2017[cited 2018 February 9]. Available from:https:\/\/www.whocc.no\/atc\/structure_and_principles\/."},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13709"},{"key":"e_1_2_11_16_1","unstructured":"Institute for Safe Medication Practices Canada.ISMP List of High\u2010Alert Medications in Acute Care Settings[Internet]. ISMP Canada;2017[cited 2018 January 25]. Available from:https:\/\/www.ismp.org\/Tools\/institutionalhighAlert.asp."},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-014-1668-z"},{"key":"e_1_2_11_18_1","unstructured":"KennedyM.Review of Medication Incidents Reported in Irish Hospitals: National Learning 2016[Internet]. State Claims Agency;2017[cited 2018 January 25]. Available from:http:\/\/stateclaims.ie\/wp\u2010content\/uploads\/2017\/11\/Medication\u2010Incidents\u2010Report\u20102016.pdf."},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.071761"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aeu313"},{"key":"e_1_2_11_21_1","first-page":"309219","article-title":"Recent advances in epidural analgesia","volume":"2012","author":"Bauer M","year":"2012","journal-title":"Anesthesiol Res Pract"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03530010043033"},{"key":"e_1_2_11_23_1","unstructured":"Institute for Healthcare Improvement.The Five Rights of Medication Administration[Internet]. Cambridge MA: IHI;2017[cited 2017 March 14th]. Available from:http:\/\/www.ihi.org\/resources\/Pages\/ImprovementStories\/FiveRightsofMedicationAdministration.aspx."},{"key":"e_1_2_11_24_1","unstructured":"CRICO.Medication\u2010related Malpractice Risks: CRICO 2016 CBS Benchmarking Report[Internet]. CRICO;2017[cited 2018 January 25]. Available from:https:\/\/www.rmf.harvard.edu\/Malpractice\u2010Data\/Annual\u2010Benchmark\u2010Reports\/Risks\u2010in\u2010Medication."},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270003254786"},{"key":"e_1_2_11_26_1","unstructured":"Health Service Executive (HSE).Building a Better Health Service: Annual Report and Financial Statements 2016 [Internet]. Dublin: HSE;2017[cited 2019 April 10]. Available from:https:\/\/www.hse.ie\/eng\/services\/publications\/corporate\/annual\u2010report\u2010and\u2010annual\u2010financial\u2010statements\u20102016.pdf."},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30461-6"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2753.2006.00634.x"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbcp.14035","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.14035","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bcp.14035","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.14035","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T01:31:29Z","timestamp":1694309489000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bcp.14035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,23]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["10.1111\/bcp.14035"],"URL":"https:\/\/doi.org\/10.1111\/bcp.14035","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,23]]}}}